GlassScriptPhysician profile
Tanu Garg
NPI 1659752376
$1,973.09
in general payments reported to CMS, 2019-2025
20 companies · $227 in 2025
The $227 reported for 2025 was less than what a typical Vascular Neurology provider received nationally (typical 2025 total: $360).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $143 · 2020: $145 · 2021: $463 · 2022: $335 · 2023: $375 · 2024: $286 · 2025: $227.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $888.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $887.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $459.95 | 2020-2025 | Repatha, Repatha |
| Ucb, INC. | $184.35 | 2022-2025 | Briviact, Rystiggo |
| Astrazeneca Pharmaceuticals LP | $183.83 | 2021-2024 | Andexxa |
| Genentech USA, INC. | $183.37 | 2019-2022 | |
| Avanir Pharmaceuticals, INC. | $132.83 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $131.35 | 2020-2025 | Eliquis |
| Otsuka America Pharmaceutical, INC. | $125.26 | 2023-2024 | Nuedexta |
| Silk Road Medical, INC. | $106.16 | 2021 | |
| Pfizer INC. | $86.83 | 2020-2023 | |
| Janssen Pharmaceuticals, INC | $67.18 | 2022-2024 | Xarelto |
| Boston Scientific Corporation | $56.21 | 2024-2025 | Bodyguardian |
| Portola Pharmaceuticals, LLC | $55.10 | 2020 | |
| Genzyme Corporation | $47.63 | 2025 | |
| Alexion Pharmaceuticals, INC. | $33.80 | 2021-2023 | Ultomiris |
| Abbvie INC. | $26.56 | 2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $24.57 | 2023 | Kcentra |
| Novartis Pharmaceuticals Corporation | $21.91 | 2025 | |
| Chiesi USA, INC. | $16.23 | 2021 | |
| Saol Therapeutics INC. | $15.73 | 2020 | |
| Merz North America, INC. | $14.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tanu Garg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.